LaktoBio Enterosgel sachet №10

Description

LaktoBio  Pharmachologic effect
The active ingredient of enterosgel is methylsilicic acid in the form of a hydrogel. The drug belongs to enterosorbents. Has a detoxifying effect when taken orally. The organic silicon matrix of methylsilicic acid hydrogel effectively absorbs from the blood (due to the action through the membranes of the villi of the intestinal mucosa cells) and from the intestinal contents the products of incomplete metabolic reactions, medium molecular weight toxic substances (with a molecular weight of 70-1000) and incorporated radionuclides. After absorption, it removes them from the body in the feces. Also binds and removes microorganisms (opportunistic and pathogenic). Does not inhibit col-, lacto- and bifidobacteria due to reduced adhesiveness of normal intestinal microflora. It relieves the manifestations of toxicosis, normalizes laboratory parameters of urine and blood, improves the functioning of the liver, kidneys and intestines. Prevents the development of erosive and ulcerative lesions of the mucous membrane of the gastrointestinal tract under the influence of aggressive external factors due to the enveloping action. Improves parietal digestion. Activates peristaltic bowel movements, does not cause atony. The drug is not absorbed into the systemic circulation. Stabilizes immune responses through effective detoxification.

LaktoBio  Indications for use
• Infectious-toxic liver diseases (viral hepatitis A and B, toxic hepatitis, liver cirrhosis, hepatocholecystitis);

• kidney disease, especially with the development of chronic renal failure (glomerulonephritis, pyelonephritis, polycystic kidney disease, etc.);

• cholestasis of various origins, including the addition of allergic reactions and liver failure;

• diseases of the gastrointestinal tract (enterocolitis, gastritis, colitis, diarrhea, post-resection syndrome, gastric ulcer and duodenal ulcer, etc.);

• food and drug allergies, infectious-allergic and atopic bronchial asthma, atopic dermatitis, eczema urticaria, etc.);

• diarrhea and dyspepsia of non-infectious origin,

• infectious diseases (salmonellosis, food poisoning, dysentery, rotavirus infections);

• intoxication (including narcotic, burn, purulent-septic and alcoholic intoxication);

• skin diseases (neurodermatitis, diathesis, etc.);

• early preeclampsia,

• complex treatment of intestinal dysbiosis,

• malignant diseases (for detoxification before and after surgery, during radiation or chemotherapy).

LaktoBio  Mode of application
Enterosgel is administered orally. The dosage form – paste – is completely ready for use. The duration of treatment is determined individually. On average, the duration of therapy is 7-14 days, in case of severe intoxication, the dose may be doubled in the first 3 days of therapy. With obstructive jaundice, cirrhosis of the liver, it is possible to prescribe a longer time (2 months or more). Enterosgel should be taken with a sufficient amount of water. The drug should be taken between meals (2 hours after taking food or medicine or 1.5-2 hours before taking). The daily dose (45 g for adults) is divided into 3 doses. Single dosage – 1 tablespoon (15 g) – for adults. In pediatrics: children under 3 years old – 1 teaspoon (5 g) 2 times a day (daily dose – 10 g); children 3-5 years old – 1 teaspoon 3 times a day (daily dose – 15 g), children 5-14 years old – 1 dessert spoon (10 g) 3 times a day (daily dose – 30 g).

LaktoBio  Side effects
Constipation may occur (especially in patients with a tendency to constipation) in the first days of taking the drug. With the development of constipation, it is recommended to carry out a cleansing enema (in the first 2 days of using Enterosgel).

Contraindications
Enterosgel is not prescribed for acute intestinal obstruction. After the elimination of intestinal obstruction, enterosgel is not contraindicated.

Pregnancy

Enterosgel is not contraindicated in pregnancy and lactation.

Interaction with other medicinal products:

Enterosgel can be used in complex therapy, subject to the timing of the intake of Enterosgel in relation to other drugs, including adaptogens, immunomodulators, bacterial drugs (lactobacilli, bifidobacteria) and phytopreparations.

Overdose
When the daily and single doses are exceeded, no negative effect on the body has yet been described.

Release form
Paste for internal use in containers 135; 270; 405 g. The plastic container is packed in a cardboard box.

Storage conditions
Enterosgel is stored at a temperature of 15-25 ° C. After opening the container, the drug should be protected from drying out. Shelf life is 3 years. Available without a prescription.

Composition
Active ingredient: methylsilicic acid hydrogel (in 100 g of the preparation – 70 g).

Auxiliary ingredients: purified water, sweetener.